Cargando…

Pharmacokinetic, Pharmacogenetic, and Other Factors Influencing CNS Penetration of Antiretrovirals

Neurological complications associated with the human immunodeficiency virus (HIV) are a matter of great concern. While antiretroviral (ARV) drugs are the cornerstone of HIV treatment and typically produce neurological benefit, some ARV drugs have limited CNS penetration while others have been associ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nwogu, Jacinta Nwamaka, Ma, Qing, Babalola, Chinedum Peace, Adedeji, Waheed Adeola, Morse, Gene D., Taiwo, Babafemi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061948/ https://www.ncbi.nlm.nih.gov/pubmed/27777797 http://dx.doi.org/10.1155/2016/2587094

Ejemplares similares

Associations between efavirenz concentrations, pharmacogenetics and neurocognitive performance in people living with HIV in Nigeria
por: Nwogu, Jacinta N., et al.
Publicado: (2021)

Comparison of efavirenz levels in blood and hair with pharmacy refills as measures of adherence and predictors of viral suppression among people living with HIV in Nigeria
por: Nwogu, Jacinta N., et al.
Publicado: (2022)

Phenotyping and genotyping of CYP2C19 using comparative metabolism of proguanil in sickle‐cell disease patients and healthy controls in Nigeria
por: Adejumo, Olufunmilayo E., et al.
Publicado: (2016)

Race/ethnicity difference in the pharmacogenetics of bilirubin-related atazanavir discontinuation
por: Leger, Paul, et al.
Publicado: (2018)

Pharmacogenetics of tenofovir and emtricitabine penetration into cerebrospinal fluid
por: Decloedt, Eric H., et al.
Publicado: (2021)

Effects of Pharmacogenetics on the Pharmacokinetics and Pharmacodynamics of Tamoxifen
por: de Vries Schultink, Aurelia H. M., et al.
Publicado: (2015)

Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and Pharmacodynamics
por: Brunet, Mercè, et al.
Publicado: (2022)

Nevirapine-Based Antiretroviral Therapy Impacts Artesunate and Dihydroartemisinin Disposition in HIV-Infected Nigerian Adults
por: Fehintola, Fatai A., et al.
Publicado: (2012)

Ticagrelor: Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Profile: An Update
por: Teng, Renli
Publicado: (2015)

Pharmacokinetics, Pharmacodynamics and Pharmacogenetics of Tacrolimus in Kidney Transplantation
por: Yu, Meng, et al.
Publicado: (2018)

Secondary CNS myeloma with remission after systemic CNS-penetrating agents
por: Fernandez, Luis G, et al.
Publicado: (2022)

High-efficiency pharmacogenetic ablation of oligodendrocyte progenitor cells in the adult mouse CNS
por: Xing, Yao Lulu, et al.
Publicado: (2023)

Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative review
por: Adejumo, Olurotimi A, et al.
Publicado: (2015)

Pharmacokinetic, pharmacodynamic, and pharmacogenetic assays to monitor clopidogrel therapy
por: Alvitigala, Bhawani Yasassri, et al.
Publicado: (2020)

Significant Pharmacokinetic Interactions Between Quinine and Ampicillin–Cloxacillin Combination
por: Falade, Olubunmi B., et al.
Publicado: (2016)

Selected CNS Outcomes Among INSTI Antiretrovirals
por: Wohl, David, et al.
Publicado: (2017)

CNS penetration of potential anti-COVID-19 drugs
por: Richardson, Peter J., et al.
Publicado: (2020)

Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics
por: de Man, Femke M., et al.
Publicado: (2018)

Review of Pharmacokinetics and Pharmacogenetics in Atypical Long-Acting Injectable Antipsychotics
por: Toja-Camba, Francisco José, et al.
Publicado: (2021)

Pharmacogenetics of the Central Nervous System—Toxicity and Relapse Affecting the CNS in Pediatric Acute Lymphoblastic Leukemia
por: Sági, Judit C., et al.
Publicado: (2021)

Low heritability in pharmacokinetics of talinolol: a pharmacogenetic twin study on the heritability of the pharmacokinetics of talinolol, a putative probe drug of MDR1 and other membrane transporters
por: Matthaei, Johannes, et al.
Publicado: (2016)

Self-reported sulphonamide hypersensitivity reactions in adults living in Ibadan, Nigeria: A cross-sectional, community-based study
por: Mary, Akpan Richard, et al.
Publicado: (2015)

Influence of pharmacogenetic variability on the pharmacokinetics and toxicity of the aurora kinase inhibitor danusertib
por: Steeghs, Neeltje, et al.
Publicado: (2010)

Proton Pump Inhibitors in Pediatrics: Mechanism of Action, Pharmacokinetics, Pharmacogenetics, and Pharmacodynamics
por: Ward, Robert M., et al.
Publicado: (2013)

A 30-years Review on Pharmacokinetics of Antibiotics: Is the Right Time for Pharmacogenetics?
por: Baietto, Lorena, et al.
Publicado: (2014)

Cyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin's lymphoma
por: Veal, Gareth J., et al.
Publicado: (2016)

The Impact of Pharmacogenetics on Pharmacokinetics and Pharmacodynamics in Neonates and Infants: A Systematic Review
por: Yalçin, Nadir, et al.
Publicado: (2022)

Individualization of Mycophenolic Acid Therapy through Pharmacogenetic, Pharmacokinetic and Pharmacodynamic Testing
por: Winnicki, Wolfgang, et al.
Publicado: (2022)

Adverse drug reactions reporting practice and associated factors among community health extension workers in public health facilities, Southwest, Nigeria
por: Adedeji, Waheed Adeola, et al.
Publicado: (2021)

Boceprevir and Antiretroviral Pharmacokinetic Interactions in HIV/HCV Co-infected Persons: AIDS Clinical Trials Group Study A5309s
por: Kiser, Jennifer J., et al.
Publicado: (2017)

Pharmacokinetic Parameters of Quinine in Healthy Subjects and in Patients with Uncomplicated Malaria in Nigeria: Analysis of Data using a Population Approach
por: Adehin, Ayorinde, et al.
Publicado: (2019)

Corrigendum: Therapeutic Potentials of Antiviral Plants Used in Traditional African Medicine With COVID-19 in Focus: A Nigerian Perspective
por: Attah, Alfred Francis, et al.
Publicado: (2021)

Therapeutic Potentials of Antiviral Plants Used in Traditional African Medicine With COVID-19 in Focus: A Nigerian Perspective
por: Attah, Alfred Francis, et al.
Publicado: (2021)

First‐in‐human trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of zagociguat (CY6463), a CNS‐penetrant soluble guanylyl cyclase stimulator
por: van Kraaij, Sebastiaan J. W., et al.
Publicado: (2023)

Lead and Cadmium Levels in Residential Soils of Lagos and Ibadan, Nigeria
por: Adeyi, Adebola A., et al.
Publicado: (2017)

Bisphenol-A (BPA) in Foods commonly consumed in Southwest Nigeria and its Human Health Risk
por: Adeyi, Adebola A., et al.
Publicado: (2019)

Pharmacokinetic and pharmacogenetic determinants of the activity and toxicity of irinotecan in metastatic colorectal cancer patients
por: Rouits, E, et al.
Publicado: (2008)

Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women
por: Mutagonda, Ritah F., et al.
Publicado: (2017)

Developmental Pharmacogenetics of SLCO2B1 on Montelukast Pharmacokinetics in Chinese Children
por: Li, Qian, et al.
Publicado: (2019)

Population Pharmacokinetic, Pharmacogenetic, and Pharmacodynamic Analysis of Cyclophosphamide in Ethiopian Breast Cancer Patients
por: Ahmed, Jemal Hussien, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_392flvgj103fole82vmtbqtt35